OpenURL Connection Search

Select item for more details and to access through your institution.

Rapidly progressive amyotrophic lateral sclerosis is associated with microglial reactivity and small heat shock protein expression in reactive astrocytes.
Published in:
Neuropathology & Applied Neurobiology, 2019, v. 45, n. 5, p. 459, doi. 10.1111/nan.12525
By:
- Gorter, R. P.;
- Stephenson, J.;
- Nutma, E.;
- Anink, J.;
- Jonge, J. C.;
- Baron, W.;
- Jahreiβ, M.‐C.;
- Belien, J. A. M.;
- Noort, J. M.;
- Mijnsbergen, C.;
- Aronica, E.;
- Amor, S.
Publication type:
Article
There is no increased risk for colorectal cancer and adenomas in patients with diverticulitis: a retrospective longitudinal study.
Published in:
Colorectal Disease, 2010, v. 12, n. 11, p. 1122, doi. 10.1111/j.1463-1318.2009.01992.x
By:
- Lam, T. J.;
- Meurs-Szojda, M. M.;
- Gundlach, L.;
- Belien, J. A. M.;
- Meijer, G. A.;
- Mulder, C. J.;
- Felt-Bersma, R. J. F.
Publication type:
Article
Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases.
Published in:
2014
By:
- Goos, J A C M;
- Hiemstra, A C;
- Coupé, V M H;
- Diosdado, B;
- Kooijman, W;
- Delis-Van Diemen, P M;
- Karga, C;
- Beliën, J A M;
- Menke-van der Houven van Oordt, C W;
- Geldof, A A;
- Meijer, G A;
- Hoekstra, O S;
- Fijneman, R J A;
- DeCoDe PET group
Publication type:
journal article
Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases.
Published in:
British Journal of Cancer, 2014, v. 111, n. 4, p. 749, doi. 10.1038/bjc.2014.354
By:
- Goos, J A C M;
- Hiemstra, A C;
- Coupé, V M H;
- Diosdado, B;
- Kooijman, W;
- Delis-Van Diemen, P M;
- Karga, C;
- Beliën, J A M;
- Menke-van der Houven van Oordt, C W;
- Geldof, A A;
- Meijer, G A;
- Hoekstra, O S;
- Fijneman, R J A
Publication type:
Article
Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis.
Published in:
British Journal of Cancer, 2013, v. 109, n. 9, p. 2445, doi. 10.1038/bjc.2013.608
By:
- Goos, J A C M;
- Coupe, V M H;
- Diosdado, B;
- Delis-Van Diemen, P M;
- Karga, C;
- Beliën, J A M;
- Carvalho, B;
- van den Tol, M P;
- Verheul, H M W;
- Geldof, A A;
- Meijer, G A;
- Hoekstra, O S;
- Fijneman, R J A
Publication type:
Article
Gross genomic damage measured by DNA image cytometry independently predicts gastric cancer patient survival.
Published in:
2009
By:
- Belien, J. A. M.;
- Buffart, T. E.;
- Gill, A. J.;
- Broeckaert, M. A. M.;
- Quirke, P.;
- Meijer, G. A.;
- Grabsch, H. I.
Publication type:
journal article
Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients.
Published in:
2009
By:
- Ruiz, M. I. Galleges;
- Floor, K.;
- Steinberg, S. M.;
- Grünberg, K.;
- Thunnissen, F. B. J. M.;
- Belien, J. A. M.;
- Meijer, G. A.;
- Peters, G. J.;
- Smit, E. F.;
- Rodriguez, J. A.;
- Giaccone, G.;
- Galleges Ruiz, M I;
- Grünberg, K
Publication type:
journal article

Found: 7

Rapidly progressive amyotrophic lateral sclerosis is associated with microglial reactivity and small heat shock protein expression in reactive astrocytes.

There is no increased risk for colorectal cancer and adenomas in patients with diverticulitis: a retrospective longitudinal study.

Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases.

Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases.

Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis.

Gross genomic damage measured by DNA image cytometry independently predicts gastric cancer patient survival.

Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients.